Rankings
▼
Calendar
DAWN Q4 2021 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$51,000
Operating Income
-$22M
Net Income
-$22M
EPS (Diluted)
$-1.93
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$5M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$290M
Total Liabilities
$9M
Stockholders' Equity
$281M
Cash & Equivalents
$284M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$51,000
$0
—
Operating Income
-$22M
-$6M
-257.7%
Net Income
-$22M
-$34M
+36.2%
← FY 2021
All Quarters
Q1 2022 →